Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)
NCT01390857 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 379
Last updated 2017-05-17
Summary
The purpose of this post-marketing surveillance study is to collect and assess information on safety and efficacy of valaciclovir in pediatric patients with chickenpox
Conditions
- Varicella
Interventions
- DRUG
-
Valaciclovir
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Eligibility
- Max Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-11-30
- Primary Completion
- 2008-09-30
- Completion
- 2010-05-31
More Related Trials
-
Palatability Testing of a New Paediatric Formulation of Valacyclovir
NCT01682109 ·Status: COMPLETED ·Phase: PHASE4
-
Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection
NCT00098046 ·Status: COMPLETED ·Phase: PHASE3
-
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
NCT00306293 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons
NCT00079911 ·Status: TERMINATED ·Phase: PHASE4
-
Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2
NCT01346475 ·Status: COMPLETED ·Phase: PHASE4
-
Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected Patients
NCT00127608 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Vacyless® Versus Valtrex® in Patients With Herpes Zoster
NCT02152800 ·Status: COMPLETED ·Phase: PHASE4
-
VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.
NCT00116844 ·Status: COMPLETED ·Phase: PHASE4
-
A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients
NCT00042328 ·Status: COMPLETED ·Phase: PHASE2
-
Neonatal Phase 1 Valacyclovir Study
NCT05468619 ·Status: COMPLETED ·Phase: PHASE1
-
Should We Use Oral Valacyclovir in Acute Herpetic Gingivostomatitis in Children?
NCT02738229 ·Status: COMPLETED ·Phase: PHASE2
-
Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV
NCT00527618 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.
NCT00158860 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2
NCT00362297 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics of Valacyclovir Oral Solution in Children
NCT04081480 ·Status: TERMINATED ·Phase: NA
-
Valacyclovir in Neonatal Herpes Simplex Virus Disease
NCT04448392 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients
NCT00002084 ·Status: COMPLETED ·Phase: NA
-
A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients
NCT00005663 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes
NCT00306787 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Treatment of Herpes Simplex Encephalitis (HSE) With Valacyclovir
NCT00031486 ·Status: COMPLETED ·Phase: PHASE3
-
Valaciclovir Hydrochloride Phase III for Hematopoietic Stem Cell Transplantation Patients
NCT01602562 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)
NCT01453075 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients
NCT00002000 ·Status: COMPLETED ·Phase: NA
-
Valaciclovir to Prevent Transmission of Herpes Simplex Virus
NCT00001649 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected Patients
NCT00001038 ·Status: COMPLETED ·Phase: PHASE3